Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...
Hosted on MSN4d
Big Pharma’s Worst Nightmare or a Total Ripoff? The Truth About Hims’ Cheap Weight Loss PlansHims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
AURORA, CO / ACCESS Newswire / January 31, 2025 / Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal ...
Insider Monkey on MSN10d
Aristotle Atlantic Focus Growth Strategy Increased its Holdings in Eli Lilly and Company (LLY)Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...
The growing use of AI has opened new avenues for healthcare marketers, revolutionising how they approach new initiatives.
On Friday, a new far-reaching case joined the club: a class action for invasion of privacy brought against LiveRamp Holdings Inc., a public company headquartered in San Francisco that describes itself ...
Knight Therapeutics is a multinational company that develops and acquires innovative pharmaceutical products from drugmakers in Canada and Latin America. Knight’s product profile includes drugs ...
Local News Matters on MSN15d
Identity crisis: Lawsuit alleges tech company violated privacy laws by reselling client dataSAN FRANCISCO’S FEDERAL court is home to some of the country’s most ambitious lawsuits, including suits against Big Oil for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback